Influenza A: Antigenic Shift and Drift

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

How does neuraminidase contribute to the pathogenesis of influenza following the inhalation of the virus?

  • By inhibiting the function of macrophages and T cells, thus suppressing the immune response.
  • By clearing the protective mucous layer, allowing viral access to respiratory tract cells. (correct)
  • By compromising the mucosal defenses of the respiratory tract, promoting bacterial adhesion.
  • By directly inducing the release of interferons, leading to systemic flu-like symptoms.

What is the primary mechanism by which neuraminidase inhibitors, such as oseltamivir and zanamivir, combat influenza infections?

  • By enhancing the host's interferon response, thereby amplifying the antiviral state.
  • By cleaving the sialic acid residues on the cell surface, thus preventing viral entry.
  • By preventing the virus from exiting infected cells. (correct)
  • By directly neutralizing the hemagglutinin protein, preventing viral attachment to host cells.

Why are live attenuated influenza vaccines contraindicated for pregnant women and immunocompromised individuals?

  • Because the vaccine can interfere with the development of protective antibodies against influenza.
  • Because the attenuated virus in the vaccine may cause illness in these individuals. (correct)
  • Because these vaccines contain viral antigens that may provoke an allergic reaction in susceptible individuals.
  • Because these vaccines can trigger an excessive inflammatory response, leading to severe tissue damage.

How does the antigenic shift in influenza A virus contribute to the potential for pandemic outbreaks, compared to antigenic drift?

<p>Antigenic shift introduces drastically different hemagglutinin, neuraminidase proteins, which allows the virus to evade herd immunity. (C)</p> Signup and view all the answers

What immunological mechanism provides protection against influenza re-infection?

<p>The development of antibodies to hemagglutinin, as well as antibodies to neuraminidase. (C)</p> Signup and view all the answers

A patient presents with symptoms including fever, myalgia, sore throat, and non-productive cough, 36 hours post exposure. Which diagnostic approach would allow for the most rapid and specific identification of the influenza strain?

<p>Direct fluorescent antibody (DFA) or PCR testing of a respiratory sample. (D)</p> Signup and view all the answers

Following an influenza outbreak, a research study reveals a novel mutation in the hemagglutinin protein of the circulating influenza A virus. Which immunological consequence is MOST likely to arise from this mutation within the population?

<p>Reduced efficacy of existing antibodies against the mutated strain, leading to increased susceptibility. (A)</p> Signup and view all the answers

A patient is diagnosed with influenza A and treated with oseltamivir. The patient returns 5 days later with continued symptoms and now presents with signs of bacterial pneumonia. What aspect of influenza pathogenesis MOST likely predisposed this patient to secondary bacterial pneumonia?

<p>Viral-induced damage to the respiratory epithelium and impaired mucociliary clearance. (B)</p> Signup and view all the answers

A study finds influenza B virus exhibits a different pattern of antigenic variation compared to influenza A virus. In terms of molecular mechanisms and epidemiological consequences, how does antigenic variation of influenza B typically differ from influenza A?

<p>Influenza B exhibits only antigenic drift due to gradual mutations, resulting in less dramatic antigenic changes. (C)</p> Signup and view all the answers

A child who has not been vaccinated against influenza develops a fever and is suspected of influenza B infection. To prevent the danger of Reye's syndrome, which medication should be avoided?

<p>Aspirin to reduce fever. (B)</p> Signup and view all the answers

Flashcards

Antigenic Shift

Major genetic change resulting in a completely new strain of influenza virus.

Antigenic Drift

Small, gradual mutations in the virus's surface proteins (hemagglutinin and neuraminidase) over time.

Neuraminidase

Enzyme on influenza virus's surface that clears the protective mucous layer.

Hemagglutinin (HA)

Surface glycoprotein on influenza virus; primary target of protective antibodies.

Signup and view all the flashcards

Neuraminidase Inhibitors

Inhibits the release of the influenza virus from cells, treating influenza A and B.

Signup and view all the flashcards

Reye's Syndrome

Rare, life-threatening complication with encephalopathy and liver degeneration, potentially linked to aspirin use.

Signup and view all the flashcards

Inactivated Influenza Vaccine

One type of influenza vaccine recommended for adults.

Signup and view all the flashcards

Influenza A

Respiratory virus responsible for epidemics and pandemics

Signup and view all the flashcards

Influenza B

Respiratory virus responsible for regional outbreaks

Signup and view all the flashcards

influenza C

Respiratory virus that causes mild infections.

Signup and view all the flashcards

Study Notes

  • Influenza A virus causes worldwide epidemics and pandemics
  • 16 antigenically distinct hemagglutinin types exist
  • 9 antigenically distinct neuraminidase types exist
  • Antigenic shift in influenza A results in completely new viral strains
  • Antigenic drift involves small, gradual mutations in hemagglutinin (HA) and neuraminidase (NA)
  • Drift variants appear nearly every year

Orthomyxoviridae Family

  • Influenza viruses are the only members of this family
  • They are segmented, single-stranded RNA viruses
  • They contain a helical nucleocapsid
  • They have an outer lipoprotein envelope

Viral Envelope

  • The envelope has hemagglutinin (HA) spikes
  • The envelope has neuraminidase (NA) spikes
  • Virions are pleomorphic (spherical or tubular)
  • Antigenicity changes in hemagglutinin and neuraminidase contribute to epidemics and pandemics

Infection and Symptoms

  • Neuraminidase clears mucus, allowing virus access to respiratory cells
  • Infection starts in the upper respiratory tract
  • Interferons are released
  • Cytokines peak 3-4 days post-infection, causing systemic symptoms
  • Macrophage and T cell function is lessened

Cellular Damage

  • The virus kills mucus-secreting, ciliated, and epithelial cells
  • Loss of ciliated epithelium impairs bacteria expulsion
  • This can lead to pneumonia
  • Influenza promotes bacterial adhesion
  • Pneumonia can be viral or bacterial

Symptom Development

  • Incubation is 24-48 hours
  • Symptoms include fever
  • Symptoms include myalgias (muscle pain)
  • Symptoms include headache
  • Symptoms include sore throat and cough
  • Vomiting and diarrhea are rare
  • Symptoms resolve in 4-7 days

Potential Complications

  • Pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae may occur
  • Reye's syndrome, with encephalopathy and liver degeneration, is a rare but life-threatening complication
  • Reye's syndrome is common in children after influenza B or chickenpox (varicella)
  • Aspirin use may trigger Reye's syndrome

Diagnosis

  • Diagnosis is typically based on clinical signs
  • Lab tests available include ELISA
  • Rapid tests for physician's offices: Flu Optical Immunoassay and Flu OIA Influenza Test (detect viral antigen)
  • ZSTATFLU Flu Test detects viral neuraminidase
  • Direct fluorescent antibody (DFA) testing and PCR are also alternatives

Treatments

  • Oseltamivir (Tamiflu, oral) and Zanamivir (relenza, inhaled) are common treatments
  • Peramivir (Rapivab, IV) is another option
  • Neuraminidase inhibitors prevent virus release from cells

Prevention

  • Inactivated vaccines are recommended for adults
  • Live attenuated vaccines are recommended for children
  • Live vaccines are NOT for pregnant women or immunocompromised individuals
  • Vaccines are made in chicken eggs
  • People with egg allergies have alternative options

Immunity

  • Antibodies to hemagglutinin primarily protect against reinfection
  • Antibodies to neuraminidase are also protective

Influenza Types

  • Influenza C virus causes mild respiratory infections and no outbreaks
  • Influenza B virus causes major outbreaks
  • Transmission occurs via airborne respiratory droplets
  • Antigenic drift but not antigenic shift occurs in influenza B
  • Antigenic changes are less dramatic and frequent in inluenza B compared to influenza A

Influenza B specifics

  • Influenza B occurs primarily in winter (December to February) in the Northern Hemisphere
  • Influenza B, followed by bacterial pneumonia, causes higher mortality in older people
  • Morbidity is higher in older people and children under two years of age

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

More Like This

Use Quizgecko on...
Browser
Browser